MedTrace Logo

Sodium Lactate Infusion in GLUT1DS Patients

NCT04112862 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2022-11-23

No results posted yet for this study

Summary

This study investigates the effect of lactate infusion on epileptic discharges on EEG and seizure frequency in glucose transporter 1 deficiency syndrome (GLUT1DS) patients.

Conditions

  • GLUT1 Deficiency Syndrome
  • GLUT1DS1
  • GLUT1DS2
  • Epilepsy
  • Lactic Acid Blood Increased
  • Ketogenic Dieting

Interventions

OTHER

sodiumlactate

intravenous sodiumlactate 600mmol/L

Sponsors & Collaborators

  • Radboud University Medical Center

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-20
Primary Completion
2022-11-18
Completion
2022-11-18

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04112862 on ClinicalTrials.gov